EIP
GILD icon

Essential Investment Partners’s Gilead Sciences GILD Stock Holding History

Essential Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.5K Hold
360
– – 0.04% 155
2026
Q1 		$50.2K Hold
360
– – 0.05% 145
2025
Q4 		$44.2K Buy
+360
New +$43.8K 0.04% 139

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Essential Investment Partners's GILD Position: Q2 2026 in Review

Essential Investment Partners held its Gilead Sciences (GILD) position steady in Q2 2026 at 360 shares worth $45.5K. The position accounts for 0.04% of the portfolio, ranked #155.

Essential Investment Partners first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $50.2K in Q1 2026. 640 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Essential Investment Partners held 360 shares of Gilead Sciences worth $45.5K as of Q2 2026.
  • Essential Investment Partners left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.04% of Essential Investment Partners's portfolio in Q2 2026, its #155 holding.
  • Essential Investment Partners first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Essential Investment Partners's Gilead Sciences position peaked at $50.2K in Q1 2026.
  • 640 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Essential Investment Partners's 13F filing for Q2 2026, filed 15 Jul 2026.